
News|Articles|February 2, 2024
AJMC® in the Press, February 2, 2024
Author(s)AJMC Staff
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Advertisement
An article from
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
2
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
3
Amid SOHO Data, Reviewers of BTK Inhibitors in MCL Call for Trials
4
Cross-Trial Vitiligo Data: What Payers Can and Can't Compare
5




